Sanofi Pasteur gains access to Becton Dickinson (BD) micro system for vaccine delivery
This article was originally published in Clinica
Executive Summary
Becton Dickinson (BD) has licensed its "microneedle" drug delivery technology to French firm Sanofi Pasteur for administering the latter's human vaccine products, providing an alternative to the traditional intramuscular injections. Financial details of the agreement were not disclosed.